➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
AstraZeneca
Harvard Business School
Boehringer Ingelheim
Medtronic

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

Patent: 8,074,495

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,074,495
Title:Waggle weight and other preparatory period equipment measurements
Abstract: Disclosed is fitting at least one equipment measurement to a performer of a pre-determined activity to improve performance. Said equipment measurement is fitted via an analysis of pre-swing or pre-action movement or position, before the swing or action of the pre-determined activity is determined to begin. Said fitted equipment measurement may be used to fit at least one further equipment measurement as applicable based on a performance analysis of said performer. The fitting of golf equipment in such manner is particularly disclosed, including fitting a golf club measurement of a pre-swing rotation point location (waggle weight point) and using said measurement to further fit a golf club measurement (waggle weight) about said rotation point location based on golfer performance. Disclosed is making golf clubs or other equipment using the at least one fitted equipment measurement. Also disclosed is the producing and using of devices to aid in fitting said equipment measurement(s) and making said equipment, including a test golf club to aid in measuring a golf club pre-swing rotation point location and a waggle weight scale with a fulcrum, its fulcrum placed at a location corresponding to a fitted golf club pre-swing rotation point location.
Inventor(s): Kostuj; William Alan (Glendale Heights, IL)
Assignee:
Application Number:12/455,916
Patent Claims:see list of patent claims

Details for Patent 8,074,495

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial 2024-10-28 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Merck
Medtronic
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.